SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-14-000421
Filing Date
2014-08-11
Accepted
2014-08-11 16:29:55
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED 6/30/2014 appy_10q-063014.htm 10-Q 539524
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 10689
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 10811
4 EXHIBIT 32 ex32.htm EX-32 8115
  Complete submission text file 0001079973-14-000421.txt   5107707

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20140630.xml EX-101.INS 732759
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20140630.xsd EX-101.SCH 25494
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20140630_cal.xml EX-101.CAL 43112
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20140630_def.xml EX-101.DEF 142473
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20140630_lab.xml EX-101.LAB 558121
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20140630_pre.xml EX-101.PRE 284422
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 141030965
SIC: 2835 In Vitro & In Vivo Diagnostic Substances